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Biofilm embedded pathogens such as 
Staphylococcus spp.,  Escherichia coli, 
Pseudomonas aeruginosa, and 
Acinetobacter baumannii are difficult to 
eradicate and are major sources of 
bacterial re-infections.  New drugs are 
needed to combat these pathogens.  
Hypericum is a plant genus that contains 
species known to have antimicrobial 
properties. However, the specific 
metabolites responsible for the 
antimicrobial properties are not entirely 
known, nor have these compounds been 
tested as inhibitors of biofilm development.  
This project was designed to test pure 
metabolites isolated from the species H. 
densiflorum, H. ellipticum, H. prolificum, 
and H. punctatum as inhibitors of bacterial 
growth & biofilm formation.
Hypericum metabolites included in this 
study:
Susceptibility testing. The minimum inhibitory concentrations (MIC) & minimum bactericidal concentrations (MBC) of seven 
Hypericum spp. metabolites were measured against A. baumannii, P. aeruginosa, E. coli, and clinical Staphylococcus spp 
using Clinical Laboratory Standards Institute (CLSI) methods.  MIC is the lowest concentration of an antimicrobial agent that
results in no visible bacterial growth.  MBC is the minimum concentration required to kill 99.9% of a bacteria inoculum. 
Prevention of staphylococcal biofilm formation by metabolites from Hypericum spp. Pure metabolites from Hypericum 
spp. that demonstrated growth inhibitory properties against staphylococci were tested for their ability to prevent biofilm 
formation by planktonic S. aureus and S. epidermidis.  Biofilm formation was quantified using a microtiter plate assay.  
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METHODSABSTRACT
Evaluate novel acylphloroglucinols as 
promising new antimicrobial agents 
against significant bacterial diseases.
Measure the in vitro growth and biofilm 
inhibitory properties of Hypericum spp. 
metabolites against the bacterial 
pathogens A. baumannii, P. aeruginosa,
E. coli, S.aureus and S. epidermidis.
Hypericum prolificum
Certain members of the Hypericum genus, 
including St. John’s Wort (Hypericum 
perforatum L.), produce metabolites 
possessing antimicrobial properties.  These 
molecules may play defensive roles in 
protecting the plants from assaults by 
environmental pathogens.  
Hypericum punctatum
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CONCLUSION
Of the seven Hypericum metabolites tested, five demonstrated potent antimicrobial activity against the Gram-positive 
pathogens. None of the metabolites demonstrated activity against the Gram-negative pathogens. Interestingly, four of the 
metabolites also inhibited biofilm formation at sub-MIC concentrations. These results suggest that these molecules deserve 
further preclinical evaluation as agents to treat and prevent staphylococcal infections.
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Table 1. Antimicrobial activities of Hypericum metabolites.  All values are reported in μg/mL.
Biofilm Producing
S. epidermidis
(RP62A; ATCC 35984)
Non-Biofilm Producing
S. epidermidis
(M7)
Biofilm Producing
S. aureus
(ATCC 35556) 
Clinical MRSA 
(L32)
Compounds MIC MBC MBIC MIC MBC MBIC MIC MBC MBIC MIC MBC MBIC
1 7.81 7.81 1.95 7.81 7.81 3.91 7.81 7.81 3.91 3.91 3.91 3.91
2 3.91 3.91 1.95 3.91 3.91 1.95 7.81 7.81 1.95 3.91 3.91 7.81
3 7.81 7.81 1.95 7.81 7.81 3.91 3.91 3.91 3.91 7.81 7.81 3.91
4 3.91 7.81 3.91 3.91 7.81 3.91 3.91 3.91 7.81 7.81 7.81 7.81
5 3.91 7.81 3.91 3.91 3.91 3.91 1.95 3.91 3.91 3.91 3.91 3.91
6 >125 >125 125 >125 >125 125 >125 >125 125 >125 >125 125
7 >125 >125 >125 >125 >125 >125 >125 >125 >125 >125 >125 >125
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